#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatocellular carcinoma Acquired C1 inhibitor deficiency Mucous membrane pemphigoid Small intestine adenocarcinoma Follicular lymphoma stage III Lymphoma Crohn's disease Laryngeal squamous cell carcinoma Essential thrombocythaemia Epidermolysis bullosa Pulmonary tuberculosis Cryoglobulinaemia Herpes simplex Arteriovenous malformation Acute respiratory distress syndrome More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia refractory – Life with Disease Hypereosinophilic syndrome Mucopolysaccharidosis I Haemophilia B with anti factor IX – Treatment Brain stem glioma – Basic Information Breast angiosarcoma – Life with Disease X-linked lymphoproliferative syndrome – Trials in Disease Crigler-Najjar syndrome – Treatment Primary hyperoxaluria – Basic Information Gastrointestinal stromal tumour – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nesolicaftor ANHYDROUS CALCIUM FOLINATE Pegaspargase Imgn151 Anb032 Mb-Cart20.1 Quinapril Hydrochloride Fosaprepitant LY3848575 2,4 DICHLOROBENZYL ALCOHOL Testosterone Undecanoate LY3537021 SILYMARIN Nebivolol Hydrochloride Polatuzumab Vedotin Luspatercept Trastuzumab Deruxtecan Prs-344 Desloratadine Denosumab More therapies…

    Learn about Your Condition

    Peripheral artery restenosis Mitochondrial myopathy Micrographic skin surgery Genital infection female Anal fistula Medulloblastoma Oropharyngeal cancer recurrent Type IIa hyperlipidaemia Aortic valve disease Thymic carcinoma Nervous system disorder Laryngeal cancer stage II Open angle glaucoma Optic ischaemic neuropathy SAPHO syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • A study to evaluate the effectiveness and safety of iadademstat in adults with essential thrombocythemia who do not respond well to or cannot tolerate hydroxyurea

    Recruiting

    2 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    Investigated Drugs:
    • IADADEMSTAT
    Spain

  • A study to evaluate the effectiveness of pirtobrutinib in elderly and frail patients with mantle cell lymphoma who have not yet received treatment.

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Pirtobrutinib
    Italy

  • A study to evaluate the safety and effectiveness of tafasitamab in adults with autoimmune thrombocytopenia or autoimmune hemolytic anemia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Autoimmune haemolytic anaemia
    • Immune thrombocytopenia
    Investigated Drugs:
    • Tafasitamab
    France Italy The Netherlands Spain

  • A Study of Gene Therapy Using Modified Stem Cells for Patients with Transfusion-Dependent Beta-Thalassemia Who Need Regular Blood Transfusions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Thalassaemia beta
    • Thalassaemia
    Investigated Drugs:
    • Lenograstim
    • Autologous CD34+ cells transduced with lentiviral vector encoding the human beta globin gene
    • Plerixafor
    Italy

  • A Study of VGA039 to Prevent Bleeding in Teenagers and Adults with von Willebrand Disease Who Have Not Used Regular Preventive Treatment Before

    Recruiting

    3 1 1
    Investigated Drugs:
    • VGA039
    Austria Finland Germany Ireland Italy

  • Study of TranspoCART19 cell therapy for patients with CD19-positive acute lymphoblastic leukemia that is resistant or refractory to treatment

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Transpocart19
    Spain
Previous Page
1 2 3 4 5 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!